Polypharmacy and drug use in elderly Danish cancer patients during 1996 to 2006

Journal of Geriatric Oncology

Volumn 3, Issue 1, 2012, Pages 33-40

  Jorgensen, T L ^a,b   Herrstedt, J ^a,b   Friis, S ^c   Hallas, J ^b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

Author keywords

Aged; Drug therapy; Elderly; Geriatric oncology; Neoplasm; Polypharmacy

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIINFLAMMATORY AGENT; ANTIRHEUMATIC AGENT; ANTIULCER AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; NARCOTIC ANALGESIC AGENT; PENICILLIN G; POTASSIUM; SULFONAMIDE; THIAZIDE DIURETIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER PATIENT; CANCER REGISTRY; COLORECTAL CANCER; CONTROLLED STUDY; DENMARK; DIGESTIVE SYSTEM CANCER; DRUG USE; FEMALE; GERIATRIC CARE; HUMAN; KIDNEY CANCER; LUNG CANCER; MALE; NEOPLASM; POLYPHARMACY; POPULATION BASED CASE CONTROL STUDY; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; SEX DIFFERENCE; TREATMENT PLANNING; UTERINE CERVIX CANCER; UTERUS CANCER;

EID: 84856346266     PISSN: 18794068     EISSN: 18794076     Source Type: Journal    
DOI: 10.1016/j.jgo.2011.09.001     Document Type: Article

References (34)

1. United Nations Department of economic and social affairs. Population division. World Population Ageing 2001, 1950-2050. http://www.un.org/esa/population/publications/worldageing19502050/index.htm.
2. Extermann M. Interaction between comorbidity and cancer. Cancer Control 2007, 14:13-22.
3. Zarowitz B.J., Stebelsky L.A., Muma B.K., et al. Reduction of high-risk polypharmacy drug combinations in patients in a managed care setting. Pharmacotherapy 2005, 25:1636-1645.
4. Bjerrum L., Rosholm J.U., Hallas J., Kragstrup J. Methods for estimating the occurrence of polypharmacy by means of a prescription database. Eur J Clin Pharmacol 1997, 53:7-11.
5. Viktil K.K., Blix H.S., Moger T.A., Reikvam A. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol 2007, 63:187-195.
6. Bjerrum L., Sogaard J., Hallas J., Kragstrup J. Polypharmacy: correlations with sex, age and drug regimen. A prescription database study. Eur J Clin Pharmacol 1998, 54:197-202.
7. Riechelmann R.P., Moreira F., Smaletz Ò., Saad E.D. Potential for drug interactions in hospitalized cancer patients. Cancer Chemother Pharmacol 2005, 56:286-290.
8. Corcoran M.E. Polypharmacy in the older patient with cancer. Cancer Control 1997, 4:419-428.
9. Flood K.L., Carroll M.B., Le C.V., Brown C.J. Polypharmacy in hospitalized older adult cancer patients: experience from a prospective, observational study of an oncology-acute care for elders unit. Am J Geriatr Parmacother 2009, 7:151-158.
10. Hanigan M.H., dela Cruz B.L., Thompson D.M., et al. Use of prescription and nonprescription medications and supplements by cancer patients during chemotherapy: questionnaire validation. J Oncol Pharm Practice 2008, 14:123-130.
11. Puts M.T.E., Costa-Lima B., Monette J., et al. Medication problems in older, newly diagnosed cancer patients in canada: how common are they? A prospective pilot study. Drugs Aging 2009, 26:519-536.
12. Sokol K.C., Knudsen J.F., Li M.M. Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect management. J Clin Pharm Ther 2007, 32:169-175.
13. Girre V., Arkoub H., Puts M.T.E., et al. Potential drug interactions in elderly cancer patients. Crit Rev Oncol Hematol 2010, 10.1016/j.critrevonc.2010.05.004.
14. Gaist D., Sorensen H.T., Hallas J. The Danish prescription registries. Dan Med Bull 1997, 44:445-448.
15. Kildemoes H.W., Sørensen H.T., Hallas J. The Danish National Prescription Registry. Scand J Public Health 2011, 39(7 Suppl.):38-41.
16. Pedersen C.B. The Danish civil registration system. Scand J Public Health 2011, 39(Suppl. 7):22-25.
17. Storm H.H., Michelsen E.V., Clemmensen I.H., Pihl J. The Danish Cancer Registry - history, content, quality and use. Dan Med Bull 1997, 44:535-539.
18. Gjerstorff M. The Danish Cancer Registry. Scand J Public Health 2011, 39(Suppl. 7):42-45.
19. World Health Organisation Collaborating Centre for Drug Statistics Methodology ATC Classification Index with DDDs 2003, WHO Collaborating Centre for Drug Statistics Methodology, Oslo. http://www.whocc.no/atc_ddd_index/.
20. Langholz B., Goldstein B. Risk set sampling in epidemiologic cohort studies. Statistical Science 1996, 11:35-53.
21. Macleod U., Mitchell E.D., Burgess C., et al. Risk factors for delayed presentation and referral of symptomatic cancer: evidence for common cancers. Br J Cancer 2009, 101:S92-S101.
22. Extermann M., Crane E.J., Boulware D. Cancer in nonagenarians: profile, treatments and outcomes. J Geriatr Oncol 2010, 1:27-31.
23. Lazarovici C., Khodabakhshi R., Leignel D., Fabre-Guillevin E., Minard A., Gisselbrecht M. Factors leading oncologists to refer elderly cancer patients for geriatric assessment. J Geriatr Oncol 2011, 2:194-199.
24. McLean A.J., Le Couteur D.G. Aging biology and geriatric clinical pharmacology. Pharmacol Rev 2004, 56:163-184.
25. Jørgensen T.L., Hallas J., Land L.H., Herrstedt J. Comorbidity and polypharmacy in elderly cancer patients: the significance on treatment outcome and tolerance. J Geriatr Oncol 2009, 1:87-102.
26. Madsen H.K., Hallas J. Danish drug consumption trends. Ugeskr Laeger 2009, 171:775-777.
27. Kildemoes H.W., Stovring H., Andersen M. Driving forces behind increasing cardiovascular drug utilization: a dynamic pharmacoepidemiological model. Br J Clin Pharmacol 2008, 66:885-895.
28. Hallas J. Conducting pharmacoepidemiologic research in Denmark. Pharmacoepidemiol Drug Saf 2001, 10:619-623.
29. Engholm G., Ferlay J., Christensen N., et al. NORDCAN: cancer incidence, mortality, prevalence and prediction in the nordic countries. Association of Nordic Cancer Registries. Danish Cancer Society 2010, Version 3.5. http://www.ancr.nu.
30. The Danish Health Board The modernized Cancer Register - method and quality http://www.sst.dk/~/media/Indberetning%20og%20statistik/Cancerregisteret/Metodebeskrivelse_publikation%20Cancerregisteret.ashx.
31. Barat I., Andreasen F., Damsgaard E.M. The consumption of drugs by 75-year-old individuals living in their own homes. Eur J Clin Pharmacol 2000, 56:501-509.
32. Kennedy J. Herb and supplement use in the US adult population. Clin Ther 2005, 27:1847-1858.
33. Patterson R.E., Neuhauser M.L., Hedderson M.M., et al. Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs. J Altern Complement Med 2002, 8:477-485.
34. Claxton A.J., Cramer B.S., Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001, 23:1296-1310.